Comments on: Aptalis Pharma Announces FDA Approval of NDA for Oral Powder Formulation of Viread®, Co-Developed with Gilead Sciences

Comments on: Aptalis Pharma Announces FDA Approval of NDA for Oral Powder Formulation of Viread®, Co-Developed with Gilead Sciences /contractors/drug-delivery/adarepharma/pressreleases/pressfda-approval-viread/ The leading site for news and procurement in the pharmaceutical industry Wed, 18 Jan 2012 18:30:00 +0000 hourly 1 https://wordpress.org/?v=6.7.2